FTC bars POM juice’s health claims

January 23, 2013

According to the Los Angeles Times, the U.S. Federal Trade Commission (FTC) has upheld a judge’s finding that the owners of POM Wonderful pomegranate juice made false claims about the health benefits of their products.

The commission found that dozens of POM Wonderful advertisements made deceptive claims that its juice was proven to treat heart disease, prostate cancer, and erectile dysfunction. Los Angeles, Calif.-based POM Wonderful and its owners, Stewart and Lynda Resnick, had asked the FTC to overturn an administrative law judge’s May 2012 ruling that the ads were misleading. They argued that the ads were not deceptive and were protected by the 1st Amendment. The commission rejected the appeal, ordering POM Wonderful to stop making such health claims unless they were supported by two “well-controlled, human clinical trials.”

The company responded to the FTC’s decision, issuing a terse statement that said: “POM Wonderful categorically rejects the FTC’s assertion that our advertisements made any misleading disease treatment or other health claims. POM has always communicated with our consumers in a transparent, honest, and often humorous manner, delivering valuable information about the health benefits of our products. This order ignores what $35 million of peer-reviewed scientific research, centuries of traditional medicine, and plain common sense have taught us: antioxidant-rich pomegranate products are good for you.”

POM Wonderful has 60 days to ask a federal appeals court to reverse the commission’s findings.

Los Angeles Times article

FTC press release